AstraZeneca, Merck’s Lynparza to face FDA panel in prostate cancer bid as PARP scrutiny escalates aliu Thu, 03/02/2023 – 11:04 More: AstraZeneca, Merck's Lynparza to face FDA panel in prostate cancer bid as PARP scrutiny escalates Source: fierce
read morePfizer inks $183M contract manufacturing deal with Samsung Biologics kdunleavy Thu, 03/02/2023 – 09:56 More: Pfizer inks 3M contract manufacturing deal with Samsung Biologics Source: fierce
read moreBristol Myers dodges one $6.4B Celgene buyout CVR suit, but the battle is far from over aliu Thu, 03/02/2023 – 09:31 More: Bristol Myers dodges one .4B Celgene buyout CVR suit, but the battle is far from over Source: fierce
read moreEverest debuts $130M mRNA vaccine plant with aim at Chinese market dominance jkeenan Thu, 03/02/2023 – 09:23 More: Everest debuts 0M mRNA vaccine plant with aim at Chinese market dominance Source: fierce
read moreMerck KGaA, Haleon warn of more inflation challenges in 2023 fkansteiner Thu, 03/02/2023 – 09:07 More: Merck KGaA, Haleon warn of more inflation challenges in 2023 Source: fierce
read moreEuropean Medicines Agency has issued a positive opinion for the use of VLA2001 among certain adults More: Vital update for Valneva’s COVID-19 vaccine Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals